Efficacy of topical recombinant human platelet derived growth factor on wound healing in patients with chronic diabetic lower limb ulcers

Indian Journal of Surgery

Volumn 72, Issue 1, 2010, Pages 31-35

  Jaiswal, Shyam S ^a   Gambhir, R P S ^a   Agrawal, Amit ^a   Harish, S ^a  

^a ARMED FORCES MEDICAL COLLEGE   (India)

Author keywords

Chronic diabetic foot ulcer; Recombinant human platelet derived growth factor (rhPDGF)

Indexed keywords

EID: 76749130538     PISSN: 09722068     EISSN: 09739793     Source Type: Journal    
DOI: 10.1007/s12262-010-0005-8     Document Type: Article

References (22)

1. Macfarlane IA, Bliss M, Jackson JGL, William G (1991) The history of diabetes mellitus. In: Textbook of Diabetes, Vol. I. Pickup JC, Williams G (Eds.), Blackwell Science, Oxford, pp. 1-21.
2. Aboderin I, et al. Life course perspectives on coronary heart disease, stroke and diabetes: key issues and implications for policy and research. Geneva, WHO, 2001 (document WHO/NMH/NPH/01. 4) quoted in WHO (2003), Tech Rep. Ser N 916: 5.
3. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2002. Atlanta, GA: US Dept of Health and Human Services, Centers for Disease control and Prevention, 2002. Available at: http://www.cdc.gov/diabetes/pubs/estimates.htm.
4. Powers Alvin C (2005) Diabetes mellitus. In: Harrison's Principles of Internal Medicine. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL (Eds.), 16th edition, McGraw-Hill pp. 2152-2180.
5. Eugelgan MM, Geiss LS, Saaddine JB, et al. (2004) The evolving diabetes burden in the United States. Ann Intern Med 140: 945-950.
6. Moulik PK, Mtonga R, Gill GV (2003) Amputation and mortality in new onset diabetic foot ulcers stratified by etiology. Diabetes Care 26: 491-494.
7. Brem H, Sheehan P, Boulton AJM (2004) Protocol for treatment of diabetic foot ulcers. Am J Surg 187(5A): 1S-10S.
8. Steed DL (1997) The role of growth factors is wound healing. Surg Clin North Am 77: 575-586.
9. Nagai MK, Embil JM (2002) Becaplermin: Recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers. Expert Opin Biol Ther 2: 211-218.
10. Wiemen TJ, Smiell JM, Su Y (1998) Efficacy and safety of a Topical Gel formulation of Recombinant Human Platelet Derived Growth Factor BB (Becaplermin) in patients with chronic neuropathic diabetic ulcers. Diabetes Care 21: 5.
11. Boulton AJM, Armstrong DG (2006) The diabetic foot. In: Clinical Diabetes: Translating Research into Practice. 1st edition, Fonseca VA (Ed.), Elsevier, Saunders, pp. 179-195.
12. International Association of Enterostomal Therapists (1988) Dermal wounds: Pressure sores: Philosophy of the IAET. Journal of Enterostomal Therapy 15: 4-17.
13. Shobhana R, Rama Rao P, Lavanya A, Viswanathan V, Ramachandran A (2000) Cost burden to diabetic patients with foot complications - a study from southern India. JAPI 48: 1147-1150.
14. Koveker GB (2000) Growth factors in clinical practice. Int J Clin Pract 54(9): 590-593.
15. Papanas N, Maltezos E (2007) Growth factors in the treatment of diabetic foot ulcers: new technologies, any promises? Int J Low Extrem wounds 6(1): 37-53.
16. Steed DL (2006) Clinical evaluation of recombinant human platelet derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 117(7 Suppl): 143S-149S.
17. Margolis DJ, Bartus C, Hoffstad O, Berlin JA (2005) Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers. Wound Repair Regen 13(6): 531-536.
18. Harrison-Balestra C, Eaglstein WH, Falabela AF, Kirsner RS (2002) Recombinant human platelet-derived growth factor for refractory nondiabetic ulcers: A retrospective series. Dermatol Surg 28(8): 755-759.
19. Cohen MA, Eaglstein WH (2001) Recombinant human platelet-derived growth factor gal speeds healing of acute full-thickness punch biopsy wounds. J Am Acad Dermal 45(6): 857-862.
20. Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH (1999) Efficacy and safety of becaplermin (recombinant human platelet derived growth factor-BB) in patients with non-healing, lower extremity diabetic ulcers: A combined analysis of four randomized trials. Wound Repair Regen 7: 335-346.
21. Schaffer M, Coerper S, Becker HD (2001) Gene therapy in diabetic foot. Kongressbd Dtsch Ges Chir Kongr 118: 825-828.
22. Loot MA, Kenter SB, Au FL, et al. (2002) Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell Biol 81(3): 153-160.